- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 223/08 - Oxygen atoms
Patent holdings for IPC class C07D 223/08
Total number of patents in this class: 48
10-year publication summary
|
7
|
3
|
5
|
2
|
2
|
1
|
3
|
2
|
5
|
1
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Glaxosmithkline Intellectual Property Development Limited | 773 |
4 |
| Merck Patent GmbH | 5663 |
3 |
| BioMarin Pharmaceutical Inc. | 384 |
3 |
| Novira Therapeutics, Inc. | 32 |
3 |
| Total Research & Technology Feluy | 442 |
3 |
| Capstan Therapeutics, Inc. | 30 |
3 |
| Bristol-myers Squibb Company | 4812 |
2 |
| BASF SE | 21129 |
2 |
| Life Technologies Corporation | 3385 |
2 |
| Chiesi Farmaceutici S.p.A. | 957 |
2 |
| Ono Pharmaceutical Co., Ltd. | 419 |
2 |
| Sirna Therapeutics, Inc. | 102 |
2 |
| Libra Therapeutics, Inc. | 10 |
2 |
| ReNAgade Therapeutics Management Inc. | 56 |
2 |
| Merck Sharp & Dohme Corp. | 2184 |
1 |
| Janssen Pharmaceutica N.V. | 3234 |
1 |
| Takeda Pharmaceutical Company Limited | 2721 |
1 |
| Dana-Farber Cancer Institute, Inc. | 2645 |
1 |
| Jiangsu Hecheng Display Technology Co., Ltd. | 187 |
1 |
| Northern Innovations and Formulations Corp. | 16 |
1 |
| Other owners | 7 |